Alternatives to Kaleido
Compare Kaleido alternatives for your business or organization using the curated list below. SourceForge ranks the best alternatives to Kaleido in 2026. Compare features, ratings, user reviews, pricing, and more from Kaleido competitors and alternatives in order to make an informed decision for your business.
-
1
Superpower
Superpower
Superpower is a comprehensive digital health platform designed to help individuals live longer, prevent disease, and optimize their well-being. By combining whole-body testing with personalized health programs, Superpower provides members with an all-in-one health membership that includes testing for hormones, thyroid function, heart health, toxins, genetics, microbiome, cancer risk, and more. Members receive an annual roadmap detailing actionable steps to enhance various aspects of their health, transitioning from uncertainty to control. The platform offers access to a private concierge clinician, enabling members to communicate via text for assistance with orders, scheduling, questions, and coaching. Superpower also features a curated marketplace of health products, tests, and services at insider prices, with new additions weekly. Personalized programs target areas such as gut health, hormone optimization, aging, toxin exposure, disease risk, body composition, etc. -
2
Solvuu
Solvuu
A data science platform for life scientists. Translate your microbiome research into practical applications. Bring novel, safe and effective products to market faster. Integrate the right set of data science and collaboration tools, and achieve rapid advances in cancer therapeutics. Accelerate research, enable innovation and create value by adopting effective digital technology solutions to improve crop productivity. Import your small and big data. Organize according to our templates, or define your own schema. Our format inference algorithm synthesizes parsing functions and lets you override if needed, without coding. Use our interactive import screens or CLI for bulk imports. Your data is not just bytes. Solvuu automatically computes relevant summary statistics and generates rich interactive visualizations. Explore and gain insights into your data immediately; slice and dice as needed. -
3
Mahalo Health
Mahalo Health
Mahalo Health is a unified digital health platform designed to accelerate the development of patient-centric digital health applications and clinical trials. By offering prebuilt modules. Mahalo enables rapid deployment of white-label apps tailored to specific therapeutic areas. The platform's unified data capabilities include a predictive health engine for disease prediction and diagnosis, a behavior change engine to promote positive patient actions, and a notification engine for timely communications via push, SMS, or email. Ensuring robust security and compliance, Mahalo adheres to standards like HIPAA, GCP, ISO27001, and GDPR. Its services span various therapeutic areas, including diabetes, cognitive health, cardiovascular conditions, musculoskeletal disorders, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH).Starting Price: Free -
4
OmicsBox
BioBam Bioinformatics S.L.
OmicsBox is a leading bioinformatics solution that offers end-to-end data analysis of genomes, transcriptomes, metagenomes, and genetic variation studies. The application is used by top private and public research institutions worldwide and allows researchers to easily process large and complex data sets, and streamline their analysis process. It is designed to be user-friendly, efficient, and with a powerful set of tools to extract biological insights from omics data. The software is structured in different modules, each with a specific set of tools and functions designed to perform different types of analysis, such as de-novo genome assemblies, genetic variation analysis, differential expression analysis, and taxonomic classifications of microbiome data, including the functional interpretation and rich visualizations of results. The functional analysis module includes the popular Blast2GO annotation methodology and makes OmicsBox particularly suited for non-model organism researchStarting Price: €100/month/seat -
5
Sumondo
Sumondo
Lack of motion is responsible for some of the life style diseases like diabetes and stress. These diseases happen including obesity you get, because you eat a poor diet and lack of exercise. If you smoke and otherwise live unhealthily, you risk getting cancer, cardiovascular disease and possibly blood clots due to high cholesterol. Finally, stress is also a common lifestyle disease that affects many people, both people in work and the unemployed. Stress is a symptom of a state where you do not feel you can live up to its own or others’ expectations. Loneliness is fairly widespread in Nordic countries can also lead to depression. -
6
IPM.ai
IPM.ai
Specialty and rare diseases have undefined patient populations, with individuals who are undiagnosed or misdiagnosed, healthcare providers who are unaware of disease states and their manifestations, as well as treatment journeys that are not well understood. IPM.ai is an Insights-as-a-Service (IaaS) company that empowers the world’s leading life sciences brands to better understand and improve the lives of patients through the development, clinical study, and commercialization of therapeutic interventions. Maximize commercialization efforts by forecasting market size, competitive landscape, and potential ROI. Uncover ideal patients who are undiagnosed and/or misdiagnosed who may be appropriate for disease interception and therapeutic intervention. Statistically model the number of disease cases present in a particular patient population at a given time. Identify physicians who diagnose and treat ideal patients and influence other health care providers. -
7
Healnet
Healx
Rare diseases are often not well studied and there is a limited understanding of many of the aspects necessary to support a drug discovery program. Our AI platform, Healnet, overcomes these challenges by analyzing millions of drug and disease data points to find novel connections that could be turned into new treatment opportunities. By applying frontier technologies across the discovery and development pipeline, we can run multiple stages in parallel and at scale. One disease, one target, one drug: it's an overly simple model, yet it's the one used by nearly all pharmaceutical companies. The next generation of drug discovery is AI-powered, parallel and hypothesis-free. Bringing together the key three drug discovery paradigms. -
8
BIOVIA Discovery Studio
Dassault Systèmes
Today’s biopharmaceutical industry is marked by complexity: growing market demands for improved specificity and safety, novel treatment classes and more intricate mechanisms of disease. Keeping up with this complexity requires a deeper understanding of therapeutic behavior. Modeling and simulation methods provide a unique means to explore biological and physicochemical processes down to the atomic level. This can guide physical experimentation, accelerating the discovery and development process. BIOVIA Discovery Studio brings together over 30 years of peer-reviewed research and world-class in silico techniques such as molecular mechanics, free energy calculations, biotherapeutics developability and more into a common environment. It provides researchers with a complete toolset to explore the nuances of protein chemistry and catalyze discovery of small and large molecule therapeutics from Target ID to Lead Optimization. -
9
DDxHub
Rustemsoft
Diagnosis is the process of determining which disease or health condition explains a person's test results and symptoms. DDxHub - Differential diagnosis Hub is the System distinguishing of a particular disease or health condition from others that present similar symptoms and lab test results. DDxHub is a concentrator that holds a lot of disease descriptions. DDxHub is useful when you try to find a right diagnosis by comparing several different possible diagnoses. You may enter your own disease definition into DDxHub repository and share the disorder descriptions with other DDxHub users around the world. In turn, you will be updated with disorder descriptions from other DDxHub users. Join the thousands healthcare professionals and patients who already love DDxHub's differential diagnosis, sync, and disorders description sharing solution. DDxHub is useful for clinical therapeutics students at medical schools as educational resource.Starting Price: $39/year/user -
10
BioDigital Human
BioDigital
The BioDigital Human is an interactive 3D software platform for visualizing anatomy, disease, and treatment. Our software makes health information visual, simple, and engaging. Interactive 3D is a proven way to increase comprehension and speed in anatomy, disease, and treatment education. Create and manage interactive visualizations to use across all your digital channels, at a fraction of the traditional cost. Create custom visualizations using Human Studio, or work with our professional services team to visualize specific conditions and treatments. Embed interactive 3D visualizations into any LMS or digital solution for a seamless end-user experience. For the first time organizations can quickly make their health, medical, and life science education more immersive using BioDigital’s software. Interactive 3D models of human anatomy, physiology, disease, and treatments can be tailored for specific learning, then embedded directly within a curriculum or any type of education material. -
11
Recursion
Recursion
Recursion is a TechBio company focused on transforming drug discovery by combining biology, data, and artificial intelligence. Founded over a decade ago, the company pioneered the use of large-scale cellular imaging to train AI models that decode the biological drivers of disease. Recursion’s mission is to deliver better medicines through novel insights and precision design, reducing the high failure rates of traditional drug development. Its proprietary Recursion OS platform integrates massive biological datasets with machine learning to accelerate discovery from target identification to clinical development. The company has built an advanced pipeline of potential first-in-class and best-in-class therapies targeting aggressive cancers and rare diseases. Automated wet labs and robotics enable millions of experiments per week, feeding continuous learning into its AI models. -
12
DoseMeRx
DoseMeRx
DoseMeRx is the world’s first and largest Bayesian dosing platform designed for clinical practice. Reach your clinical targets faster with our Bayesian dosing platform, clinically proven to significantly improve patient outcomes and lower costs. We’re the only Bayesian dosing platform in the world that’s HITRUST certified. Rest easy knowing that we insist on the highest level of patient data security and integrity. Achieve continuity of care across your health system in just a few clicks. Standardize workflows and optimize your therapeutic drug monitoring program with ease. We have a range of drug models across various therapeutic areas including; vancomycin and infectious disease, transplant medicine, cardiovascular and coagulation management, oncology and pediatrics. -
13
Mesh Bio
Mesh Bio
Based on proven medical science and explainable systems biology, DARA enables and enhances clinical decision support and intervention guidance. We work with healthcare providers and stakeholders to provide digital solutions that transform health screening and chronic disease management. We enable digital transformation of care delivery through clinical workflow automation and predictive analytics, built on gold standard clinical guidelines and best practices. We help physicians engage with patients better by providing actionable health insights through personalized disease risk and adverse event predictions. We guide pharmaceutical development by revealing pharmacodynamics in complex biological processes and find novel therapeutic interventions. Predictive analytics on multidimensional patient data will enable personalized precision medicine in the management of cardiometabolic disease to prevent catastrophic patient outcomes. -
14
BIOiSIM
VERISIMLife
BIOiSIMTM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illnesses or diseases. We offer a range of translational-based solutions, customized for your pre-clinical and clinical programs. These offerings are all centered around our proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses. Our models are built on data from thousands of compounds across 7 species, leading to robustness rarely seen in the industry. With a focus on human outcomes, the platform has at its core a translatability engine that transforms insights across species. The BIOiSIMTM platform can be used before the preclinical animal trial start, allowing earlier insights and savings in expensive outsourced experimentation. -
15
OMS Trace Analytics
Objective Medical Systems
Enhance value-based care with the OMS Trace Analytics® cloud platform for the analysis and reporting of critical cardiovascular metrics. Increasingly reimbursement is being tied to value. For example, for the performance year 2018, 60% of Medicare reimbursements are being linked to quality under the Quality Payment Program. The need for a discrete data and evidence-based quality reporting solution to measure, target and improve your quality program is more critical than ever. The OMS Trace Analytics® cloud platform is designed to deliver deep clinical insights for cardiovascular diseases with dedicated dashboards for leading cardiovascular diseases like Hypertension, Dyslipidemia, Atrial Fibrillation, Heart Failure, Coronary Artery Disease and Peripheral Artery Disease. -
16
Sofpromed
Sofpromed
Sofpromed provides electronic data capture (EDC) systems for biotechnology, pharmaceutical, and medical device companies conducting phase I-IV clinical trials. An EDC system is a software tool used to collect, clean, and export data in clinical trials. Sofpromed’s EDC application is used in clinical trials worldwide across multiple therapeutic areas, including oncology, hematology, cardiovascular, metabolic, central nervous system (CNS), dermatology, infectious diseases, respiratory diseases, and pain, among others. Clear design, intuitive, and very easy to use. Quick data entry and navigation. Access control and data encryption. Fully web-based, no installations required. Daily data backups, seamless service. Works in multiple devices, browsers, and operating systems. Built-in monitoring, data management, and reporting tool. Meets HIPAA, GCP, and 21 CFR. Convenient billing model. monthly flat rate. -
17
Clinipace
Clinipace
We deliver a level of collaboration and control not possible in a traditional CRO environment. Our goal is to guide you successfully throughout your clinical development program. At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment, with an emphasis on personalized services and solutions, regulatory expertise, and therapeutic leadership. Our mission is to improve the way clinical research is performed in major therapeutic areas including oncology, rare disease, gastroenterology, nephrology, and women’s health. Clinipace strives to impact the future of drug development and health care by combining the most advanced technology and a challenge accepted approach. -
18
Mass Dynamics
Mass Dynamics
Discover biological biomarkers, create insights into disease mechanisms, discover new drugs or identify changes in protein levels from a set of carefully designed experiments. We’ve made it easy to start unlocking the power of MS and Proteomics so you can focus on the biological complexity and move closer to the moment of discovery. Our automated and repeatable workflow allows for quicker experiment startup and turnaround times, giving you the control and flexibility to make and act on decisions in the moment. Allowing you to focus on biological insights and human-to-human collaboration, our proteomics data processing workflow is built to scale, repeatedly. We’ve pushed heavy and repetitive processing to the cloud, enabling a seamless and enjoyable experience. Our intelligent Proteomics workflow seamlessly integrates complex moving parts to enable larger experiments to be processed and analyzed with ease. -
19
BioSymetrics
BioSymetrics
We integrate clinical and experimental data using machine learning to navigate human disease biology and advance precision medicines. Our patent-pending Contingent AI™ understands relationships within the data to provide sophisticated insights. We address data bias by iterating on machine learning models based upon decisions made in the pre-processing and feature engineering stages. We leverage zebrafish, cellular and other phenotypic animal models to validate in silico predictions in vivo experiments and genetically modify them in vitro and in vivo, to improve translation. Using active learning and computer vision on validated models for cardiac, central nervous system and rare disorders, we rapidly incorporate new data into our machine learning models. -
20
AIATELLA
AIATELLA
Every year, cardiovascular diseases claim over 20 million lives worldwide. Many of these deaths could be prevented with early detection. Yet, the global healthcare system is overwhelmed, and limited by human capacity for detailed analysis. That's where AIATELLA steps in. Our groundbreaking AI-powered image analysis solution transforms the landscape of cardiovascular diagnostics. By automating manual measurements of vasculature in a quantified way and using historical data, we drastically cut down on the time, cost, and level of expertise needed, significantly expanding the capacity for critical imaging. AIATELLA's solution improves the speed, accuracy, and precision of diagnostics, delivering measurements and disease-progression analysis in seconds instead of hours. By improving the speed, accuracy, and variability in the analysis we are enabling the doctors to spend more time with patients and enabling true preventative and personalized medicine for all. -
21
Dexur aggregates claims data from multiple sources and coupled with innovative algorithms, we can show various insights to Life Sciences organizations including Sales and Marketing, Disease Burden Data, HEOR & RWE, Patient Journey, etc. Dexur utilizes its anonymized claims database to build disease burden data & dashboards at the national, regional, and hospital level. The outcomes for a specific disease (e.g., Diabetes, Chronic Kidney Disease) include the total cost of care, readmission, mortality, nursing home costs, length of stay, and any metric relevant to the disease. Dexur’s Life Sciences App Suite provides deep insights into various financial and clinical quality metrics that help in the analysis of Hospitals, Ambulatory Surgery Centers (ASC’s), Providers, and IDN’s. This helps life sciences companies have a more organised approach in targeting their products and services to most suitable clients.Starting Price: $10 per user per month
-
22
GPT-Rosalind
OpenAI
GPT-Rosalind is a purpose-built frontier reasoning model developed by OpenAI to accelerate scientific research across biology, drug discovery, and translational medicine. It is designed specifically for life sciences workflows, where researchers must navigate large volumes of literature, experimental data, and specialized databases to generate and validate new ideas. It combines deep domain understanding in areas such as chemistry, genomics, protein engineering, and disease biology with advanced tool-use capabilities, allowing it to interact with scientific databases, analyze experimental outputs, and support complex, multi-step reasoning tasks. It can assist with evidence synthesis, hypothesis generation, literature review, sequence interpretation, and experimental planning, helping scientists move faster from raw data to actionable insights. GPT-Rosalind transforms complex, time-intensive research processes into more efficient AI-assisted workflows. -
23
Omada
Omada Health
Digital Care Made Human™. Omada® empowers people to achieve their health goals through sustainable lifestyle change. Comprehensive Digital Care. Enrolling in multiple programs is hard. That’s why our comprehensive, people-led program offers your employees 24/7 support, personalized to their health needs. Prediabetes@2x Prevention Prevention. Fast facts: 1 in 3 Americans have prediabetes. With Omada’s Prevention program: Omada’s Prevention program projected to lower risk for Type 2 Diabetes by 30% and heart disease by 13%. Participants who completed Omada’s Prevention program lost around 4-5% of their body weight on average—and most keep it off. Type_2_Diabetes@2x Diabetes Diabetes close button Fast Facts: 46% of patients with diabetes do not achieve adequate glycemic control (A1C < 7%). 4 With Omada’s Diabetes program: 92% of participants were satisfied with the program. Participants not at goal reduced their A1C by over 1%. Hypertension. Fast Facts: 46% of of the US population -
24
SpliceCore
Envisagenics
Using RNA sequencing (RNA-seq) data and Artificial Intelligence are both a necessity and an opportunity to develop therapeutics that target splicing errors. The use of machine learning enables us to discover new splicing errors and quickly design therapeutic compounds to correct them. SpliceCore is our dedicated AI platform for RNA therapeutics discovery. We developed this technology platform specifically for the analysis of RNA sequencing data. It can identify, test and validate hypothetical drug targets faster than traditional methods. At the heart of SpliceCore is our proprietary database of more than 5 million potential RNA splicing errors. It is the largest database of splicing errors in the world and it is used to test every RNA sequencing dataset that is input for analysis. Scalable cloud computing enables us to process massive amounts of RNA sequencing data efficiently, at higher speed and lower cost, exponentially accelerating therapeutic innovation. -
25
Health Dialog
Health Dialog
Whether seeking treatment for a common cold or a chronic condition like diabetes or heart disease, when people are sick or have a family member facing illness, they often have questions, concerns, or could use guidance to ensure they understand and are able to adhere to their treatment. Health Dialog offers a suite of personalized population health solutions that address these issues and empower your members to improve their whole-being health, while reducing overall costs. Our healthcare experts provide one-on-one health coaching through personalized outreach to help identified members better manage their chronic conditions, such as asthma, diabetes and heart disease. We identify members at-risk for nonadherence, determine the best method for engaging them, and educate them to encourage ongoing medication-taking behavior. Give your members 24/7 access to a live registered nurse who can provide clinical advice, refer services, impart skills and provide relevant educational materials. -
26
AlphaFold
DeepMind
These exquisite, intricate machines are proteins. They underpin not just the biological processes in your body but every biological process in every living thing. They’re the building blocks of life. Currently, there are around 100 million known distinct proteins, with many more found every year. Each one has a unique 3D shape that determines how it works and what it does. But figuring out the exact structure of a protein remains an expensive and often time-consuming process, meaning we only know the exact 3D structure of a tiny fraction of the proteins known to science. Finding a way to close this rapidly expanding gap and predict the structure of millions of unknown proteins could not only help us tackle disease and more quickly find new medicines but perhaps also unlock the mysteries of how life itself works. -
27
Genomenon
Genomenon
Pharma companies need comprehensive genomic information to drive successful precision medicine programs, but decisions are often made using only a fraction of the data available, about 10%. Genomenon delivers 100% of the data. An efficient and cost-effective natural history research solution for pharma, ProdigyTM Patient Landscapes support the development of rare disease therapies by enhancing insights contained in retrospective and prospective health data. Using a powerful AI-driven approach, Genomenon delivers a comprehensive and expert assessment of every patient in the published medical literature, in a fraction of the time. Don’t miss anything, get insight into every genomic biomarker published in the medical literature. Every scientific assertion is supported by empirical evidence from the medical literature. Identify all genetic drivers and pinpoint which variants are known to be pathogenic according to ACMG clinical standards. -
28
THB
THB
Detailed recommendations across the continuum of care across each step of the patient journey. Clear call-to-action to enable and monitor detailed commercial and clinical outcomes. Disease-specific risk algorithms implemented across diabetes, cardiovascular, kidney health, liver health, amongst other therapies. Complete Wellness Score to assess the risk of inpatient intervention. Proprietary data and protocols backed customer-friendly clinical content. Ready to use and ready to customize multi-format and multi-purpose content. Intelligent decision support – powered by protocols as well as machine learning on prescribers’ prescription patterns. Most advanced customer feedback system custom-built for healthcare enterprises. Multi-parameter engine basis spend, timely compliance, preventive checkup, clinical parameter / outcome improvement, demographics, among other things. -
29
Elucid
Elucid
Deliver personalized patient care with the only histologically validated, objective, and quantitative CTA-based arterial analysis software. Utilize ground-truth histology to visualize the source of myocardial ischemia and inform heart attack and stroke risk. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated. Current non-invasive testing cannot visualize the biology deep inside artery walls where heart disease develops. Elucid is harnessing scientific imaging and artificial intelligence to enable quick, accurate, noninvasive diagnoses and precise treatment of cardiovascular disease to enable better patient outcomes. Assess plaque composition with histology-validated software. Quantify heart attack and stroke risk with greater accuracy. Visualize a comprehensive and objective view of arterial disease to enable personalized treatment plans before a patient ever enters the hospital. -
30
BenevolentAI
BenevolentAI
BenevolentAI is an AI-enabled drug discovery platform and scientific technology company that unites advanced artificial intelligence, machine learning, and domain-specific science to accelerate the discovery, design, and development of new medicines for complex diseases by making sense of vast, diverse biomedical data and generating actionable scientific insights faster than traditional methods. Its proprietary Benevolent Platform ingests and harmonizes structured and unstructured biomedical information, including literature, genomics, clinical information, and multi-omics data, into a comprehensive knowledge graph, enabling scientists to reason across biological systems, generate hypotheses, predict novel drug targets, and design candidate molecules with higher confidence and lower failure rates. -
31
Oncoustics
Oncoustics
Oncoustics is creating and deploying advanced and patented AI solutions for low-cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical needs. Oncoustics offers a suite of disease and anatomy-focused apps that work on any PoC ultrasound and can be used by any MD/nurse/tech as a basic primary care office instrument, without the need to look at images. Oncoustics’ AI solutions turn the inexpensive point-of-care ultrasound devices into powerful diagnostic tools for faster, cost-effective detection and monitoring of diseases including diseases in the liver, prostate, kidney, breast, and thyroid. Our team is made up of experts in AI, signal processing, radiology, hepatology, digital health, and ultrasound. Inexpensive point of care diagnosis and surveillance improves outcomes through early detection and monitoring resulting in effective disease management. -
32
DeLorean AI Medical AI
DeLorean AI
Medical AI is a true technology solution that comprehensively addresses chronic diseases. The hallmarks of this technology are its ability to predict, generate the next-best actions, and present the outputs in an easy-to-consume user experience. DeLorean Medical AI augments human capabilities and creates a future where we can trust both the machine and the human to make the best decisions. Our technology has been shown to improve outcomes and is the first AI to be biologically validated through third-party clinical tests. With the ability to better classify patient populations, assign risk, and predict disease state transitions, Medical AI directly leads to earlier detection and diagnosis of diseases. It can also reduce costs. Having been installed for 10+ clients, it has demonstrated both cost reductions and savings associated with real-time predictions to determine at-risk populations and next-best-action recommendations based on statistical probabilities. -
33
Kolexia Smart Data
Med.Else
Maximize the impact of your scientific communication by selecting the best experts in the areas of excellence suited to your objectives. From common therapeutic areas to the rarest diseases, with Kolexia optimize your recruitment strategy for KOLs* in line with your objectives thanks to an intuitive interface and precise scientific and digital qualification of the identified profiles. Kolexia has a unique database, bringing together various information on health experts and their activities. This wealth of data allows an in-depth analysis of their profiles and their collaborations, as well as a better understanding of their impact in their field of expertise. Through this approach, we provide a comprehensive and up-to-date view from opinion leaders for an optimized medical strategy. *KOL : Key Opinion Leader -
34
NeuroBlu
Holmusk
Behavioral health is a fundamental and persistently overlooked aspect of overall health. Mental and substance use disorders impact a staggering 970 million people worldwide, with over US $1 trillion in global economic burden each year. Despite the skyrocketing crisis, progress has lagged behind other disease areas. Less than half of those living with major depression, the most widespread mental illness, reach remission on currently available treatments. Recent rising awareness has driven demand in a system unequipped to support the depth and breadth of need. There is a debilitating evidence gap that inhibits research and innovation, stemming from inherent limitations in behavioral health: complex disease etiologies, lack of quantifiable biomarkers, and institutional silos. Despite decades of research, we still do not know how to alleviate most behavioral health disorders. -
35
InSilicoTrials
InSilicoTrials
InSilicoTrials.com is a web-based platform, which provides a user-friendly computational modeling and simulation environment where many integrated easy-to-use in silico tools are readily available. The platform targets primarily users from the medical devices and pharmaceutical sectors. The in silico tools available for medical devices enable computational testing in different biomedical areas like radiology, orthopedics and cardiovascular during product design, development and validation processes. For the pharmaceutical sector, the platform provides access to in silico tools developed at all stages of the drug discovery and development processes and for many different therapeutic areas. We have built the only cloud-platform based on the crowdscience concept that makes it easy to use validated models and cut your R&D costs now. A growing catalogue of models ready to be used, on a pay per use basis. -
36
Evidation Health
Evidation
We measure health outside of formal healthcare settings to better understand disease burden. Our comprehensive view of the patient unlocks business opportunities through new measures of disease and patient health. Develop a patient-centered understanding of disease impact on everyday function to activate physicians and payers, and to guide patient support. Create the algorithms that predict disease onset, progression/regression, or identify key intervention point. Generate support for the benefits of your products using real world digital data. A technology-enabled service for conducting real world research that incorporates novel, everyday behavior data to support clinical, medical affairs, and commercial teams, leveraging Evidation's virtual site, Achievement. Flexible study design, device integration strategies, and protocol management for centralized and streamlined study operations. We can sponsor or you can. -
37
BrainSightAI
BrainSightAI
BrainSightAI is a health tech company leveraging artificial intelligence and machine learning to revolutionize brain mapping through AI-based connectomics, generating personalized brain maps. Our VoxelBox products utilize AI-based connectomics to generate personalized brain maps. These tools aim to enhance pre-surgical planning and improve outcomes for patients with brain tumors and other neurological conditions. BrainSightAI collaborates with leading hospitals nationwide to conduct clinical trials focused on various brain-based disorders, including Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Our mission is to advance brain science and enhance lives by providing cutting-edge tools for understanding the human brain. -
38
OpenEvidence
OpenEvidence
OpenEvidence is an AI-powered clinical decision support platform designed for verified health care professionals, which aggregates, synthesizes, and visualizes peer-reviewed medical evidence to answer point-of-care questions rapidly and reliably. The system covers over 160 specialties and more than 1,000 diseases or therapeutic areas, presenting results grounded in high-quality sources such as JAMA, NEJM, and clinical guidelines. It supports a deep, intuitive search interface that returns evidence-based answers in 5–10 seconds, always with citations, and ensures transparency by surfacing the references behind each answer. In addition to search, OpenEvidence includes features like “Visits,” a module that transcribes patient encounters, enriches documentation with clinical intelligence, drafts notes, and integrates assessment and plan guidance into clinician workflows.Starting Price: Free -
39
Causaly
Causaly
Leverage the power of AI to expedite the journey from bench research and laboratory insights to the launch of life-changing therapies. Gain up to 90% in research productivity by reducing your reading time from months to minutes. Cut through the noise with a high-precision, high-accuracy search to navigate the ever-growing volume of scientific literature with ease. Save time, reduce bias and increase odds of novel discoveries. Deeply explore disease biology and conduct advanced target discovery. Causaly’s high-precision knowledge graph consolidates evidence from millions of publications, making deep, unbiased scientific exploration possible. Rapidly navigate biological cause-and-effect relationships without being an expert. Get a view of all scientific documents and uncover hidden connections. Causaly’s powerful AI machine reads millions of published biomedical literature to support better decision-making and research outcomes. -
40
Bruker Drug Discovery
Bruker
Bringing a new drug into the market, from the first step to the final market introduction, is a time-consuming, highly regulated, and expensive process, which can take a decade or more. Final success crucially depends on the early availability of accurate analytical results, fast enough for taking the right decisions at the beginning of the development and minimizing late attrition rates. Today’s drug development is mainly based on a rational approach where typically establishing the biological target to focus on is the first key step. This target identification requires a deep understanding of the candidates´ properties to identify the most promising ones as quickly and reliable as possible. Once a biological target has been established, finding the most promising lead molecules is often seen as the next challenge. Typically, lead discovery is the identification of potential drug candidates – either small organic molecules or biologic assemblies with therapeutic potential. -
41
Qritive
Qritive
Making cancer diagnosis fast, accurate, and affordable. During our lifetime, 1 in 3 of us will get cancer. But cancer diagnosis is slow and expensive because doctors are not equipped with modern automated tools. Qritive provides an AI-powered solution to help doctors analyse both microscopy images and text from patient data. As a result, hospitals will be more efficient in making cancer diagnoses, allowing them to save costs. Pantheon is a CE marked vendor-agnostic digital pathology platform that enables digitization of the entire pathology lab workflow and telepathology, supports rich report generation, and provides a platform for AI analysis of pathology whole-slide images. Differentiates a wide range of benign diseases and malignancies in breast tissue. -
42
Cleerly
Cleerly
Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. We design intelligent clinical technologies to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis, plaque build-up in the heart's arteries, not indirect markers such as risk factors and symptoms of the disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease diagnostics and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes. Cleerly empowers providers to go beyond traditional measures of heart disease by analyzing, characterizing, and quantifying types of plaque, so they can more accurately determine a patient's risk of heart attack and develop a treatment plan to improve heart health. -
43
Perception Health CARE
Perception Health
Manage risk more effectively and provide better care to your population with the disease prediction models in CARE™. We have a nationwide view of medical claims data that is customizable to the most micro-level for our customers. Our models analyze billions of medical claims to identify risk factors of early disease onset or surgical procedure. With this information, diagnosis and treatment happen earlier, potentially saving lives. We train our prediction models using national data, but we can also run our models on data from your EHR, population health platform, or member claims database. Furthermore, our physician matching can help you select and match providers to patients in order to optimize their care pathway for the best treatment. Our advanced disease prediction models use clinically relevant data to show who is trending towards a diagnosis of a disease or condition, allowing you to engage with them sooner to begin treatment. -
44
Evo 2
Arc Institute
Evo 2 is a genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins. It utilizes a frontier deep learning architecture to model biological sequences at single-nucleotide resolution, achieving near-linear scaling of compute and memory relative to context length. Trained with 40 billion parameters and a 1 megabase context length, Evo 2 processes over 9 trillion nucleotides from diverse eukaryotic and prokaryotic genomes. This extensive training enables Evo 2 to perform zero-shot function prediction across multiple biological modalities, including DNA, RNA, and proteins, and to generate novel sequences with plausible genomic architecture. The model's capabilities have been demonstrated in tasks such as designing functional CRISPR systems and predicting disease-causing mutations in human genes. Evo 2 is publicly accessible via Arc's GitHub repository and is integrated into the NVIDIA BioNeMo framework. -
45
Bluenod
Bluenod
Obtain a detailed profile of each Key Opinion Leader (KOL) and identified stakeholders with contact details and a general description of their activities. Collect the social profile of people active in the community of interest to target them with specific content. Have an overview of interactions through a comprehensive mapping of the community of interest. Bluenod provides valuable information to the healthcare industry by mapping therapeutic areas according to disease or medical fields. In particular, the pharmaceutical industry requests our services to inform pre- and post-launch efforts. Media organizations can boost the promotion of their content by targeting influential actors. Political organizations can pinpoint the main actors in their influence network to engage with them. Whether to inform on pre- and post-launch phases of a product release or to engage with powerful customers, Bluenod reports support the largest companies in their community of interest.Starting Price: $59.00/month/user -
46
Insight Connected Platform
Insight
Connected platform for detection and prevention. Real-time information is critical to preventing the spread of disease. Leverage IoT-enabled devices, machine learning and data analysis to monitor health and safety. Monitoring public health in crowded places — from business offices to theme parks — has become a top priority around the globe. A robust disease prevention strategy is critical to helping create a more protective environment for people and ensuring business continuity. Insight’s Connected Platform for Detection and Prevention is a flexible and scalable platform to help create smarter and safer outcomes in public spaces. Our solution unifies sensor data in a single dashboard and provides real-time health visibility. Leveraging Machine Learning, the customized application can provide notifications and guidance for social interactions that align with your organization’s requirements. -
47
VSClinical
Golden Helix
VSClinical allows for the clinical interpretation of variants based on ACMG & AMP guidelines. The VSClinical guided workflow enables following the American College of Medical Genetics (ACMG) guidelines used to identify and classify causal variants for inherited disease risk, cancer predisposition, and the diagnosis of rare diseases. The ACMG/AMP joint guidelines for variant interpretation provide a set of criteria to score variants and place them into one of five classification tiers. Following the guidelines requires deep diving into the annotations, genomic context, and existing clinical assertions about every variant. VSClinical provides a tailored workflow to score each relevant criterion while also providing all the bioinformatic, literature and evidence from clinical knowledgebases to assist in the scoring and interpretation process. VSClinical is designed to allow variant scientists to efficiently process variants. -
48
Owkin
Owkin
Patients from around the world suffer from complex diseases and a staggering variety of symptoms. However, they share one thing in common: Patients have a need for faster development of safer and more effective therapies. Owkin’s mission is to empower researchers in hospitals, universities, and pharmaceutical companies to: understand why drug efficacy varies from patient to patient, enhance the drug development process, and identify the best drug for the right patient to improve treatment outcomes. Owkin Loop is the foundation of Owkin’s research platform: it connects medical researchers with high-quality datasets from leading academic research centers around the world. Owkin Loop is powered by the two main components of Owkin’s Software Stack: Owkin Studio, our machine learning platform, and Owkin Connect, our federated learning framework. Owkin medical research collaborations are in Oncology, Immunology and Cardiovascular diseases. -
49
Artrya
Artrya
Artrya partners with clinics receiving chest pain patients to deliver new models of cardiovascular care based on AI. Easily integrate plaque features of high prognostic value into the evaluation of coronary artery disease. Rapid assessment of chest pain patients in emergency and primary care settings. We see a world where communities do not have to be plagued by a high rate of a heart attack. AI-driven insights into the type and volume of arterial plaque detected through coronary computed tomography angiography (CCTA) facilitate the accurate stratification of chest pain patients within minutes. Quickly determine patients with minimal to zero coronary artery disease with the confidence there are no underlying plaque features that could cause future major adverse cardiac events. Catch the early warning signs of a potential heart attack. Effectively rule in at-risk patients with acute or atypical chest pain who warrant further investigation and therapy. -
50
Genedata Biologics
Genedata
Genedata Biologics® streamlines discovery of biotherapeutics including bispecifics, ADCs, TCRs, CAR-Ts, and AAVs. The most widely adopted platform across the industry, it integrates all discovery workflows so you can focus on true innovation. Accelerate research with a first-in-class platform uniquely designed from the start to digitalize biotherapeutic discovery. The platform facilitates complex R&D processes by designing, tracking, testing, and assessing novel biotherapeutics drugs. It works with any format, from antibodies, bi- or multi-specifics, ADCs, novel scaffolds, and therapeutic proteins, to engineered therapeutic cell lines such as TCRs and CAR-T cells. Acting as a central end-to-end data backbone, Genedata Biologics integrates all R&D processes, from library design and immunizations, selections and panning, molecular biology, screening, protein engineering, expression, purification, and protein analytics, to candidate developability and manufacturability assessments.
